文献速递流行病学与生物统计

缺失结局数据对系统评价疗效估计的潜在影响:插补研究

Potential impact of missing outcome data on treatment effects in systematic reviews: imputation study.
PubMed 文献 · BMJ · 2020-08-26

该插补研究纳入100篇系统评价(含653项随机对照试验),评估缺失结局数据对疗效估计的影响。应用看似合理假设时,合并相对效应估计的中位变化为1.4%至7.0%,6%至22%的荟萃分析跨越无效线,最严格假设下2%方向改变。作者建议系统评价应呈现缺失数据的影响并用于GRADE偏倚风险评级。

要点

  • 合理假设下合并效应中位变化1.4%–7.0%,22%荟萃分析跨越无效线
  • 不切实际假设下中位变化0%–30.4%,最差情景60%跨越无效线
  • 系统评价应呈现缺失数据影响并用于GRADE偏倚风险评级

核心结论

  • 即使对明确缺失数据的参与者结局应用合理假设,合并相对效应估计的平均变化仍 substantial,近四分之一(22%)的荟萃分析跨越无效线。
  • 系统评价作者应呈现缺失结局数据对效应估计的潜在影响,并用于GRADE偏倚风险评级和结果解读。

研究设计与样本

  • 插补研究,纳入100篇系统评价,共包含653项随机对照试验。
  • 纳入标准为系统评价包含组水平荟萃分析,且对患者重要二分类疗效结局有统计学显著效应。

主要发现

  • 应用不切实际但常讨论的假设时,相对效应估计的中位变化范围为0%至30.4%。
  • 跨越无效线阈值的荟萃分析百分比从1%(最佳情景)到60%(最差情景),最差情景下26%方向改变。
  • 应用合理假设时,相对效应估计的中位百分比变化范围为1.4%至7.0%。
  • 跨越无效线阈值的荟萃分析百分比从6%(IMOR 1.5)到22%(IMOR 5),最严格假设(IMOR 5)下2%方向改变。

关键数值与推荐

  • 不切实际假设:最佳情景(无事件)、所有参与者无事件、所有参与者有事件、最差情景。
  • 合理假设基于信息缺失比值比(IMOR)方法:IMOR 1.5(最宽松)、IMOR 2、IMOR 3、IMOR 5(最严格)。
  • 基于八种缺失数据处理方法进行敏感性分析。

临床怎么用

  • 系统评价作者应量化并报告缺失结局数据对效应估计的潜在影响。
  • 将缺失数据影响分析结果纳入GRADE偏倚风险评级和结果解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the risk of bias associated with missing outcome data in systematic reviews. DESIGN: Imputation study. SETTING: Systematic reviews. POPULATION: 100 systematic reviews that included a group level meta-analysis with a statistically significant effect on a patient important dichotomous efficacy outcome. MAIN OUTCOME MEASURES: Median percentage change in the relative effect estimate when applying each of the following assumption (four commonly discussed but implausible assumptions (best case scenario, none had the event, all had the event, and worst case scenario) and four plausible assumptions for missing data based on the informative missingness odds ratio (IMOR) approach (IMOR 1.5 (least stringent), IMOR 2, IMOR 3, IMOR 5 (most stringent)); percentage of meta-analyses that crossed the threshold of the null effect for each method; and percentage of meta-analyses that qualitatively changed direction of effect for each method. Sensitivity analyses based on the eight different methods of handling missing data were conducted. RESULTS: 100 systematic reviews with 653 randomised controlled trials were included. When applying the implausible but commonly discussed assumptions, the median change in the relative effect estimate varied from 0% to 30.4%. The percentage of meta-analyses crossing the threshold of the null effect varied from 1% (best case scenario) to 60% (worst case scenario), and 26% changed direction with the worst case scenario. When applying the plausible assumptions, the median percentage change in relative effect estimate varied from 1.4% to 7.0%. The percentage of meta-analyses crossing the threshold of the null effect varied from 6% (IMOR 1.5) to 22% (IMOR 5) of meta-analyses, and 2% changed direction with the most stringent (IMOR 5). CONCLUSION: Even when applying plausible assumptions to the outcomes of participants with definite missing data, the average change in pooled relative effect estimate is substantive, and almost a quarter (22%) of meta-analyses crossed the threshold of the null effect. Systematic review authors should present the potential impact of missing outcome data on their effect estimates and use this to inform their overall GRADE (grading of recommendations assessment, development, and evaluation) ratings of risk of bias and their interpretation of the results.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Kahale LA, Khamis AM, Diab B, et al. Potential impact of missing outcome data on treatment effects in systematic reviews: imputation study. BMJ. 2020. PMID: 32847800. doi:10.1136/bmj.m2898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。